HeartFlow took a $90 million step toward the $150 million it hopes to raise in a Series E round for the cardiac imaging technology it’s marketing. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across […]
HeartFlow
Report: HeartFlow’s estimated $150m Series E would make it medtech’s latest unicorn
A reported Series E round for HeartFlow, estimated at $150 million, would value the company at more than $1 billion, vaulting it into unicorn territory. Redwood City, Calif.-based HeartFlow’s FFRct technology works by taking the data from a standard CT scan and applying algorithms that result in a color-coded 3D “map” detailing the changes in flow across […]
HeartFlow wins CMS new tech payment classification for FFRct analysis
HeartFlow said today that the Centers for Medicare & Medicaid Services finalized a new technology ambulatory payment classification for its HeartFlow FFRct analysis designed to help diagnose suspected coronary artery disease. Under the newly finalized payment decision, Medicare-enrolled hospitals will be eligible for reimbursements of $1,450.50 for each technical component of the FFRct analysis. The new […]
Corindus Vascular Robotics to test-drive HeartFlow’s 3D cardiac imaging tech
Corindus Vascular Robotics (OTC:CVRS), a Massachusetts-based surgical robotics company, plans to utilize technology that creates 3D images of arteries for evaluating patients. Company officials said they’d employ California-based HeartFlow’s FFRct Analysis in a case series of robotic-assisted percutaneous coronary interventions to evaluate the technology’s role in clinical decision support. The testing will be done at hospitals […]
HeartFlow wins positive policy decisions from 3 BCBS providers
HeartFlow said today it won positive medical policies for its HeartFlow FFRct fractional flow reserve analysis system from 3 separate Blue Cross Blue Shield providers. The Redwood City, Calif.-based company said that Anthem Blue Cross Blue Shield, Blue Shield of California and Blue Cross and Blue Shield of Alabama issued positive medical policies supporting the […]
Philips, HeartFlow ink co-selling, co-dev deals
Royal Philips (NYSE:PHG) said today it inked a collaborative deal with HeartFlow to promote HeartFlow’s FFRct Analysis system along with Philips’ catheters for assessing coronary arteries in patients with suspected coronary artery disease. HeartFlow’s FFRct fractional flow reserve software is designed to aid in the diagnosis and treatment of patients with suspected coronary artery disease, providing insight […]
HeartFlow touts 4 positive BCBS policy decisions for its FFRct tech
HeartFlow said today it won positive medical policy decisions from 4 different Blue Cross Blue Shield groups across the US for its HeartFlow FFRct fractional flow reserve technology. The Redwood City, Calif.-based company said that Horizon BCBS of New Jersey, BCBS of Arizona, BCBS of Idaho and BCBS of Kansas City issued determinations supporting the use […]
GE Healthcare inks deal to integrate HeartFlow FFRct into CT scanners
GE Healthcare (NYSE:GE) said today it inked a collaborative deal with HeartFlow to integrate its FFRct fractional flow technology into GE’s computed tomography scanners. HeartFlow’s FFRct software is designed to aid in the diagnosis and treatment of patients with suspected coronary artery disease, providing insight into the extent of the CAD and the impact it is […]
HeartFlow wins AMA CPT codes for FFRct cardiac tech
HeartFlow said today it won a new set of category III Current Procedural Terminology codes from the American medical Association for its FFRct fractional flow reserve technology. The newly won CPT code application was submitted by the American College of Cardiology, the Society of Cardiovascular Computed Tomography and the Society for Cardiovascular Angiography and Interventions, […]
HeartFlow wins BCBS positive review
UPDATE: Corrected to reflect that HeartFlow won a positive review, not reimbursement, and the source was a press release, not an SEC filing. HeartFlow said today it won a positive healthcare evidence review from Blue Cross Blue Shield’s Evidence Street for its HeartFlow FFRct technology. In the review, BCBS’s Evidence Street determined that the FFRct technology […]
DJO Global names new surgical prez | Personnel Moves – June 1, 2017
DJO Global said this week that it hired Jeffery McCaully as global president of its surgical business, effectively immediately. McCaulley succeeded Brady Shirley, who was named DJO’s president & CEO in November last year. McCaulley previously served as president & CEO of Smiths Medical, as well as president of Zimmer Biomet‘s (NYSE:ZBH) global reconstructive unit, where […]
